Your Best Stock

Eli Lilly and Co LLY

US equityMarket cap rank #12Drug Manufacturers - General
$1,185.13
+$3.24 (+0.27%)
Market open · Sep 25, 3:00 pm ET
After hours $1,182.47 +0.05%
Open$1,185.02
Prev close$1,181.89
Day range$1,160.84 – $1,190.00
Volume1.11M
Market cap$1.12T
P/E (TTM)39.8
Dividend yield0.55%

Earnings

Average move on report day±7.1%last 15 reports
Closed higher10 of 1567% of the time
Best reaction+14.9%
Worst reaction-14.1%

Stock move on the day after each report

+4.7%2023/Q3-0.2%2023/Q4+6.0%2024/Q1+9.5%2024/Q2-6.3%2024/Q3+3.3%2024/Q4-11.7%2025/Q1-14.1%2025/Q2+3.8%2025/Q3+10.3%2025/Q4+9.8%2026/Q1+4.9%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q329 Oct 2026––––
2026/Q25 Aug 2026–±80.2%+4.86%Within range
2026/Q130 Apr 2026Pre Market±51.6%+9.80%Within range
2025/Q44 Feb 2026Pre Market±69.9%+10.33%Within range
2025/Q330 Oct 2025Pre Market±43.4%+3.81%Within range
2025/Q27 Aug 2025Pre Market±49.1%-14.14%Within range
2025/Q11 May 2025–±46.4%-11.66%Within range
2024/Q46 Feb 2025Pre Market±44.5%+3.35%Within range
2024/Q330 Oct 2024–±54.6%-6.28%Within range
2024/Q28 Aug 2024–±55.8%+9.48%Within range
2024/Q130 Apr 2024Pre Market±41.2%+5.96%Within range
2023/Q46 Feb 2024Pre Market±45.3%-0.17%Within range
2023/Q32 Nov 2023Pre Market±29.3%+4.66%Within range
2023/Q28 Aug 2023Pre Market±22.1%+14.87%Within range
2023/Q127 Apr 2023–±13.9%+3.74%Within range
2022/Q42 Feb 2023–±11.3%-3.47%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$22.97B+47.7% YoY
Operating profit$12.46B+77.4% YoY
Net profit$7.10B+25.3% YoY
Diluted EPS$7.94+26.2% YoY
Free cash flow$4.48B+248.8% YoY
Operating cash flow$10.69B

Revenue, last 8 quarters

$11.4BSep '24$13.5BDec '24$12.7BMar '25$15.6BJun '25$17.6BSep '25$19.3BDec '25$19.8BMar '26$23.0BJun '26

Net profit, last 8 quarters

$970.3MSep '24$4.4BDec '24$2.8BMar '25$5.7BJun '25$5.6BSep '25$6.6BDec '25$7.4BMar '26$7.1BJun '26

Profitability & balance sheet

Gross margin83.4%
Operating margin49.7%
Net margin33.5%
Return on equity102.4%
Return on assets22.0%
Return on invested capital36.4%
Current ratio1.35
Liabilities / assets76.2%
Cash & investments$8.95B
Total debt$54.91B
Net cash (debt)-$45.96B
Free cash flow / sales17.0%
Scroll to Top